Heart-Assist Devices

• 

  Subject Areas on Research

  • 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 
  • 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee. 
  • A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation. 
  • A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. 
  • A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. 
  • A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. 
  • A Machine Without an Owner's Manual. 
  • A Minimally Invasive Approach to HeartMate 3 Implantation for Systemic Ventricular Failure Following the Mustard Procedure for Transposition of the Great Arteries. 
  • A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data. 
  • A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. 
  • A contemporary review of mechanical circulatory support. 
  • A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease. 
  • A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. 
  • A global ranking approach to end points in trials of mechanical circulatory support devices. 
  • A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy. 
  • A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. 
  • A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices. 
  • A tale of two centrifugal left ventricular assist devices. 
  • A team-based approach to patients in cardiogenic shock. 
  • ABO Blood Group and Transfusions In the Intraoperative and Postoperative Period After LVAD Implantation. 
  • Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients). 
  • Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. 
  • Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. 
  • Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. 
  • Acute kidney injury and 1-year mortality after left ventricular assist device implantation. 
  • Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches. 
  • Advanced heart failure treated with continuous-flow left ventricular assist device. 
  • Advanced therapies for end-stage heart failure. 
  • Advances in the surgical treatment of heart failure. 
  • Adverse events in the use of HeartMate vented electric and Novacor left ventricular assist devices: comparing apples and oranges. 
  • After-hour ventricular assist device coverage: what level of expertise is required? 
  • Algorithm for the diagnosis and management of suspected pump thrombus. 
  • Allosensitization in cardiac transplantation: shooting at a moving target. 
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. 
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. 
  • Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. 
  • Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. 
  • Antithrombotic Strategies and Device Thrombosis. 
  • Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry. 
  • Aortic Valve Thrombus in a Patient With an Extracorporeal Left Ventricular Assist Device: The Dilemma of Management. 
  • Aortic valve ring annuloplasty is an option in left ventricular assist device patients. 
  • Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. 
  • Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial. 
  • Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation. 
  • Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support. 
  • Associations of Preimplant Red Blood Cell Distribution Width with Clinical Outcomes Among Individuals with Left Ventricular Assist Devices. 
  • BVS5000 support after cardiac transplantation. 
  • Balancing Bleeding and Clotting: The Known Unknowns of Mechanically Assisted Circulation. 
  • Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. 
  • Biomarkers in Advanced Heart Failure: Implications for Managing Patients With Mechanical Circulatory Support and Cardiac Transplantation. 
  • Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices. 
  • Bleeding and thrombosis associated with ventricular assist device therapy. 
  • Bleeding complications and blood product utilization with left ventricular assist device implantation. 
  • Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. 
  • Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality. 
  • Bridge to long-term mechanical circulatory support with a left ventricular assist device: novel use of transcatheter aortic valve replacement. 
  • Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. 
  • C-Reactive Protein Levels Predict Outcomes in Continuous-Flow Left Ventricular Assist Device Patients: An INTERMACS Analysis. 
  • Can we prevent infections in patients with left ventricular assist devices? 
  • Cangrelor use prior to left ventricular assist device surgery: a case series. 
  • Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system. 
  • Cardiac Index Declines During Long-Term Left Ventricular Device Support. 
  • Cardiac Rehabilitation After Ventricular Assist Device Implantation: A Worthwhile Exercise? 
  • Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis. 
  • Cardiac computed tomography improves the identification of cardiomechanical complications among patients with suspected left ventricular assist device malfunction. 
  • Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections. 
  • Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. 
  • Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation. 
  • Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial. 
  • Cataract surgery in patients with left ventricular assist devices. 
  • Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. 
  • Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring. 
  • Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. 
  • Characteristics of strokes associated with centrifugal flow left ventricular assist devices. 
  • Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. 
  • Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database. 
  • Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience. 
  • Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. 
  • Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. 
  • Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. 
  • Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure. 
  • Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. 
  • Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. 
  • Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. 
  • Clinical pharmacology considerations for children supported with ventricular assist devices. 
  • Combined Therapy of Ventricular Assist Device and Membrane Oxygenator for Profound Acute Cardiopulmonary Failure. 
  • Commentary: Managing the native heart in patients supported with durable left ventricular assist devices. 
  • Commentary: Shunted single-ventricle neonatal ventricular-assist device support: Are we nearing a consensus strategy? 
  • Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. 
  • Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. 
  • Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. 
  • Complete LVOT obstruction following aortic valve replacement after HeartMate II implantation. 
  • Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device. 
  • Concomitant Thoracic Aortobifemoral Bypass With Left Ventricular Assist Device Implantation. 
  • Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis. 
  • Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. 
  • Controlling axillary intra-aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one. 
  • Controversies and Challenges of Ventricular Assist Device Therapy. 
  • Cost of ventricular assist devices: can we afford the progress? 
  • Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. 
  • Currently Available Options for Mechanical Circulatory Support for the Management of Cardiogenic Shock. 
  • Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. 
  • Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. 
  • Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study. 
  • Development of a Pediatric Cardiac Mechanical Support Program. 
  • Device therapy in the management of congestive heart failure. 
  • Differential gene expression and genomic patient stratification following left ventricular assist device support. 
  • Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure. 
  • Disparities in access to left ventricular assist device therapy. 
  • Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial. 
  • Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device. 
  • Durability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device Implantation. 
  • Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. 
  • Durable mechanical circulatory support devices. 
  • Dysphagia in the setting of left ventricular assist device hemolysis. 
  • EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device. 
  • ECMO and the Intraaortic Balloon Pump: In Search of the Ideal Mechanical Circulatory Support Device. 
  • Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study. 
  • Early outcomes with durable left ventricular assist device replacement using the HeartMate 3. 
  • Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. 
  • Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography. 
  • Editorial Commentary: Determining the cost-effectiveness of mechanical circulatory support. 
  • Educating Resident and Fellow Physicians on the Ethics of Mechanical Circulatory Support. 
  • Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. 
  • Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. 
  • Effect of Socioeconomic Status on Patients Supported with Contemporary Left Ventricular Assist Devices. 
  • Effect of age on outcomes after left ventricular assist device placement. 
  • Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. 
  • Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. 
  • Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices. 
  • Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm. 
  • Enrollment in Heart Failure Clinical Trials: Insights Into Which Entry Criteria Exclude Patients. 
  • Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry. 
  • Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. 
  • Evaluation of risk indices in continuous-flow left ventricular assist device patients. 
  • Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review. 
  • Exercise blood pressure response during assisted circulatory support: comparison of the total artificial [corrected] heart with a left ventricular assist device during rehabilitation. 
  • Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy. 
  • Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. 
  • First successful bridge to cardiac transplantation using direct mechanical ventricular actuation. 
  • First-in-human experience with Aortix intraaortic pump. 
  • Functional status in left ventricular assist device-supported patients: a literature review. 
  • Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. 
  • Glenn shunt facilitated weaning of right ventricular mechanical support. 
  • HVAD: The ENDURANCE Supplemental Trial. 
  • Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. 
  • Heart Transplantation After HeartMate 3 Use Shortens Hospitalization but Might Impose Increased Risk of Rejection. 
  • Heart failure medications prescribed at discharge for patients with left ventricular assist devices. 
  • HeartMate XVE malfunction caused by fluid aspiration into the vent port. 
  • HeartMate® II continuous-flow left ventricular assist system. 
  • Heartmate III Replacement for Recurring Left Ventricular Assist Device Pump Thrombosis. 
  • Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. 
  • Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. 
  • High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry. 
  • Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010. 
  • INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure. 
  • INTERMACS: interval analysis of registry data. 
  • Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. 
  • Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality. 
  • Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal Multicenter Study. 
  • Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices. 
  • Impact of Obesity on Ventricular Assist Device Outcomes. 
  • Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. 
  • Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. 
  • Impact of left ventricular assist device bridging on posttransplant outcomes. 
  • Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. 
  • Impella Placement in a Patient With d-Transposition of the Great Arteries After Mustard Procedure. 
  • Implantable Cardioverter-Defibrillators in Patients With Left Ventricular Assist Devices: On Trial and in Need of a Trial. 
  • Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation. 
  • Implantable left ventricular assist devices: new hope for patients with end-stage heart failure. 
  • Implantation of a HeartMate 3 ventricular assist device in a 21-kg pediatric patient with Fontan failure. 
  • Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. 
  • Improved early survival with a nonsternotomy approach for continuous-flow left ventricular assist device replacement. 
  • Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. 
  • Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High. 
  • In vivo testing of a novel blood pump for short-term extracorporeal life support. 
  • Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation. 
  • Incidence, Management, and Outcomes of Trauma in Patients with a Left Ventricular Assist Device in North Carolina. 
  • Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. 
  • Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure. 
  • Indications and Outcomes for Temporary Mechanical Circulatory Support in Pediatric Patients with Cardiac Failure. 
  • Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. 
  • Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device. 
  • Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial. 
  • Initial Experience of Left Ventricular Assist Device Support for Adult Patients with Transposition of the Great Vessels. 
  • Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. 
  • Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry. 
  • Intra-aortic balloon pump trials: questions, answers, and unresolved issues. 
  • Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial. 
  • Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. 
  • Is it Time to Get More Aggressive With Aortic Valve Insufficiency During LVAD Implantation? 
  • LVAD Outflow Graft Role in Pump Thrombosis. 
  • Lead Extraction for Cardiovascular Implantable Electronic Device Infection in Patients With Left Ventricular Assist Devices. 
  • Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response. 
  • Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. 
  • Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. 
  • Left ventricular assist device destination therapy versus extended criteria cardiac transplant. 
  • Left ventricular assist device effects on metabolic substrates in the failing heart. 
  • Left ventricular assist device failure due to outflow graft compression by thrombofibrotic exudate. 
  • Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. 
  • Left ventricular assist devices as destination therapy for end-stage heart failure. 
  • Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study. 
  • Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. 
  • Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. 
  • Load-independent analysis of a pulsatile right ventricular assist device. 
  • Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. 
  • Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. 
  • Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors. 
  • Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. 
  • Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data. 
  • Low lead one ratio predicts clinical outcomes in left bundle branch block. 
  • Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. 
  • Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. 
  • Lupus and Left Ventricular Assist Devices: High-Risk for Bleeding? 
  • Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. 
  • Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study. 
  • Malpositioned left ventricular assist device cannula: diagnosis and management with transesophageal echocardiography guidance. 
  • Management of Patients With Left Ventricular Assist Devices Requiring Teeth Extraction: Is Halting Anticoagulation Appropriate? 
  • Management of cardiogenic shock complicating myocardial infarction: an update 2019. 
  • Management of cardiogenic shock. 
  • Management of epistaxis in patients with ventricular assist device: a retrospective review. 
  • Management of pediatric tachyarrhythmias on mechanical support. 
  • Management of primary graft failure after heart transplantation: Preoperative risks, perioperative events, and postoperative decisions. 
  • Managing VAD Complications: Our Growth Industry. 
  • Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation. 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy. 
  • Mechanical unloading promotes myocardial energy recovery in human heart failure. 
  • Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease. 
  • Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. 
  • Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist. 
  • Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. 
  • Methylene blue-induced serotonin syndrome after left ventricular assist device implantation: A case report and literature review. 
  • Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery. 
  • Mitral Intervention with LVAD: Preparing for Recovery. 
  • Multimodal analgesia using opioid-sparing regimen in patients undergoing left ventricular assist device implantation. 
  • Mustard Baffle Revision With Systemic Ventricular Assist Device Placement. 
  • My approach to evaluation of patients prior to high-risk PCI with left ventricular support devices. 
  • Myocardial scar in sarcoidosis by 12-lead ECG and pathology. 
  • National Landscape of Hospitalizations in Patients with Left Ventricular Assist Device. Insights from the National Readmission Database 2010-2015. 
  • Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. 
  • Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. 
  • Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. 
  • Nonpharmacologic therapy in heart failure: an overview. 
  • Novel Acoustic Biomarker of Quality of Life in Left Ventricular Assist Device Recipients. 
  • Novel approaches to clinical trials: device-related infections. 
  • Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support. 
  • Old Device, New Tricks: Exploring Axillary Intra-Aortic Balloon Pump Use in Advanced Heart Failure. 
  • One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension? 
  • Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis? 
  • OptiVol for Volume Assessment in Patients With Continuous Flow Left Ventricular Assist Device. 
  • Optimal Bridging Strategy Post-Ventricular Assist Device Implantation Remains Unclear. 
  • Optimism, Pessimism, and Pragmatism: Musings on the Cost of Medical Innovation. 
  • Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction. 
  • Outcomes After Extracorporeal Right Ventricular Assist Device Combined With Durable Left Ventricular Assist Device Support. 
  • Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry. 
  • Outcomes after implantable left ventricular assist device replacement procedures. 
  • Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure. 
  • Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation. 
  • Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. 
  • Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device. 
  • Outcomes of Laparoscopic Cholecystectomy in Patients Supported with a Left Ventricular Assist Device. 
  • Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry. 
  • PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. 
  • PREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trial. 
  • PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. 
  • Paediatric cardiomyopathy and anaesthesia. 
  • Part II: Sealing holes in the safety net. 
  • Patient selection for left ventricular assist devices. 
  • Patient selection for mechanical circulatory support. 
  • Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management). 
  • Percutaneous Intervention for Left Ventricular Assist Device Outflow Obstruction. 
  • Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock. 
  • Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. 
  • Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. 
  • Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. 
  • Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. 
  • Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis. 
  • Physiological and Psychological Stress in Patients Living With a Left Ventricular Assist Device. 
  • Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients. 
  • Planned right ventricular support for combined heart-liver transplantation. 
  • Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support. 
  • Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. 
  • Point-of-Care Rapid-Seeding Ventricular Assist Device with Blood-Derived Endothelial Cells to Create a Living Antithrombotic Coating. 
  • Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure. 
  • Post-Myocardial Infarction Heart Failure. 
  • Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. 
  • Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. 
  • Pre-operative atrial fibrillation and early right ventricular failure after left ventricular assist device implantation: a systematic review and meta-analysis. 
  • Pre-operative proteinuria in left ventricular assist devices and clinical outcome. 
  • Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. 
  • Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. 
  • Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist Device. 
  • Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. 
  • Preparedness planning before mechanical circulatory support: a "how-to" guide for palliative medicine clinicians. 
  • Presentation and management of left ventricular assist device inflow cannula malposition. 
  • Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients With Advanced Heart Failure: Insights From the ESCAPE Trial. 
  • Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support. 
  • Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement. 
  • Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients. 
  • Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. 
  • Pump speed modulations and sub-maximal exercise tolerance in left ventricular assist device recipients: A double-blind, randomized trial. 
  • Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry. 
  • Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. 
  • Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study. 
  • RAAS Inhibition to Prevent GI Bleeding: Another Reason to Do the Right Thing. 
  • Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices. 
  • Ramping up evidence-based ventricular assist device care. 
  • Re: Desmopressin Use in Refractory Gastrointestinal Bleeding in LVAD Patient. 
  • Recurrence of cardiac sarcoidosis in a heart transplant recipient. 
  • Recurrence of heart failure symptoms after LVAD placement due to bradycardia-induced inflow obstruction. 
  • Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients. 
  • Reducing ECG Artifact From Left Ventricular Assist Device Electromagnetic Interference. 
  • Relation between pressure and volume unloading during ramp testing in patients supported with a continuous-flow left ventricular assist device. 
  • Relationship between renal function and left ventricular assist device use. 
  • Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device. 
  • Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. 
  • Replacement of continuous-flow left ventricular assist device via left subcostal incision. 
  • Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction? 
  • Reply: Temporary Mechanical Circulatory Support as a Bridge to Transplantation: Return of the Intra-Aortic Balloon Pump. 
  • Resource utilization and hospital readmission associated with gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices. 
  • Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support". 
  • Response by Truby and Topkara to Letter Regarding Article, "Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality: A Propensity-Matched Analysis of the United Network of Organ Sharing Database". 
  • Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). 
  • Rethinking papillary muscle resection for refractory ventricular tachycardia in the LVAD era. A case report. 
  • Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. 
  • Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. 
  • Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. 
  • Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. 
  • Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results. 
  • Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis. 
  • Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial. 
  • Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. 
  • Risk factors for stroke on left ventricular assist devices. 
  • Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. 
  • Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. 
  • Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. 
  • Rotary pumps: new developments and future perspectives. 
  • SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients. 
  • Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. 
  • Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study. 
  • Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. 
  • Severe heart failure and mechanical circulatory support. 
  • Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016. 
  • Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation. 
  • Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes. 
  • Sex-Specific Outcome Disparities in Patients Receiving Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-analysis. 
  • Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers. 
  • Social Support Moderates the Relationship Between Perceived Stress and Quality of Life in Patients With a Left Ventricular Assist Device. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. 
  • Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices. 
  • Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review. 
  • Successful organ donation after long-term circulatory support with nonpulsatile mechanical support. 
  • Surgical Technique for Replacement of Centrifugal Left Ventricular Assist Device Through a Left Thoracotomy. 
  • Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. 
  • Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice. 
  • Surgical management of Novacor drive-line exit site infections. 
  • Surgical treatments for advanced heart failure. 
  • Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II. 
  • Temporal changes in hospital costs for left ventricular assist device implantation. 
  • Temporary extracorporeal left ventricular assist device support for implantable left ventricular assist device replacement cases. 
  • The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. 
  • The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. 
  • The ABCs of managing systolic heart failure: Past, present, and future. 
  • The Diagnostic Yield of Repeated Endoscopic Evaluation in Patients with Gastrointestinal Bleeding and Left Ventricular Assist Devices. 
  • The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. 
  • The HeartMate 6. 
  • The Risk of Stroke on Left Ventricular Assist Device Support: Steady Gains or Stalled Progress? 
  • The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. 
  • The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants. 
  • The bispectral index in the diagnosis of perioperative stroke: a case report and discussion. 
  • The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. 
  • The changing landscape of advanced heart failure therapeutics. 
  • The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. 
  • The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. 
  • The role of heart failure pharmacotherapy after left ventricular assist device support. 
  • The spectrum of complications following left ventricular assist device placement. 
  • The year in cardiovascular surgery. 
  • Thoratec VAD system as a bridge to heart transplantation. 
  • Three-Dimensional Transthoracic Echocardiography for Evaluation of Mitral Stenosis Identification of Severe Mitral Stenosis Using Real-Time Three-Dimensional Transesophageal Echocardiography During an Left Ventricular Assist Device Insertion. 
  • Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. 
  • Thrombus around the redesigned HeartWare HVAD inflow cannula: A pathologic case series. 
  • Thrombus on the inflow cannula of the HeartWare HVAD: an update. 
  • Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Left Ventricular Assist Devices. 
  • Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula. 
  • Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. 
  • Transplanting a heart with a persistent left superior vena cava. 
  • Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. 
  • Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock. 
  • Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. 
  • Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. 
  • Unexpected abrupt increase in left ventricular assist device thrombosis. 
  • Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. 
  • Use of HeartWare Ventricular Assist System for systemic ventricular support of a pediatric patient after Mustard procedure. 
  • Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. 
  • Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart. 
  • Use of a continuous-flow device in patients awaiting heart transplantation. 
  • Usefulness of 2 centrifugal ventricular assist devices in a total artificial heart configuration: A preliminary report. 
  • Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices. 
  • Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. 
  • VA-ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted? 
  • Valve-in-Ring Transcatheter Aortic Valve Replacement After Left Ventricular Assist Device Therapy. 
  • Valvular heart disease in patients supported with left ventricular assist devices. 
  • Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes. 
  • Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device. 
  • When VAD Things Happen to Good People. 
  • When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure. 
  • Who wants a left ventricular assist device for ambulatory heart failure? Early insights from the MEDAMACS screening pilot. 
  • Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. 
  • Worldwide Experience of a Durable Centrifugal Flow Pump in Pediatric Patients. 
  • iPhone in the Management of the Berlin Heart EXCOR Ventricular Assist Device. 
• 

  Keywords of People

  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic